These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3489630)

  • 1. Effect of splenopentin (SP-5) on the antibody formation in immunosuppressed mice.
    Diezel W; Eckert R; Forner K; Sönnichsen N
    Exp Clin Endocrinol; 1986 Jul; 87(2):215-8. PubMed ID: 3489630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splenopentin--influence on antibody formation in immunosuppressed animals and on phagocytic capability of human granulocytes.
    Diezel W; Eckert R; Müller GM; Forner K; Sönnichsen N
    Arch Geschwulstforsch; 1989; 59(3):161-4. PubMed ID: 2667491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenopentin (DAc SP-5)-accelerated reconstitution of antibody formation after syngeneic bone marrow transplantation.
    Eckert R; Diezel W; Schmidt R; Forner K; Volk HD
    Exp Clin Endocrinol; 1989 Sep; 94(1-2):219-22. PubMed ID: 2689191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenopentin-induced reconstitution of the immune response after total body irradiation: optimization of treatment regime.
    Eckert R; Schmidt R; Volk HD; Diezel W; Sönnichsen N; von Baehr R
    Exp Clin Endocrinol; 1989 Sep; 94(1-2):223-5. PubMed ID: 2689192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional effects of splenin32-34 on antibody formation in immunosuppressed mice.
    Diezel W; Eckert R; Forner K; Gruner S
    Biomed Biochim Acta; 1986; 45(10):1349-52. PubMed ID: 3551932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histamine receptor-bearing lymphocytes (HRL). VIII. Splenopentin-accelerated reconstitution of the immunoresponsiveness after elimination of HRL.
    Eckert R; Diezel W; Forner K; Pfüller U; Sönnichsen N; von Baehr R
    Allerg Immunol (Leipz); 1986; 32(4):267-70. PubMed ID: 2951991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of graft-vs-host reaction induced immunodeficiency by treatment with splenopentin (DAc-SP5).
    Eckert R; Volk HD; Diezel W; Maciewski J; Hiepe F; Forner K; von Baehr R
    Allerg Immunol (Leipz); 1989; 35(4):279-85. PubMed ID: 2624251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic possibilities of thymopoietin fragments (TP3 and TP4) based on experimental animal models.
    Dénes L; Szende B; Hajós G; Szporny L; Lapis K
    Drugs Exp Clin Res; 1987; 13(5):279-87. PubMed ID: 3500029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of TP-5 and its analogs on skin grafts in mice.
    Szende B; Kisfaludy L; Lapis K; Dénes L; Szporny L; Nyéke O; Schön I; Hajós G; Ember J; Constantin M
    J Immunopharmacol; 1985; 7(1):67-78. PubMed ID: 3891868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Splenopentin--modification of the maturation of T helper lymphocytes?].
    Diezel W; Volk HD; Koyka I; Forner K
    Dermatol Monatsschr; 1986; 172(9):557-9. PubMed ID: 2947823
    [No Abstract]   [Full Text] [Related]  

  • 11. [Amino acids as immunogenesis stimulants].
    Belokrytov GA; Molchanova IV; Sorochinskaia EI
    Dokl Akad Nauk SSSR; 1986; 286(2):471-3. PubMed ID: 3512220
    [No Abstract]   [Full Text] [Related]  

  • 12. [Splenopentin--modulator of immunological and behavioral reactions in secondary immunodeficiency state induced by experimental alcoholism].
    Evseev VA; Davydova TV; Fomina VG; Odariuk Iu; Repke G; Oeme P; Forner K
    Biull Eksp Biol Med; 1991 Jun; 111(6):637-9. PubMed ID: 1893194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of the recruitment of epidermal Langerhans cells by splenopentin.
    Gruner S; Diezel W; Strunk D; Zwirner A; Sönnichsen N; Anhalt GJ
    Arch Dermatol Res; 1990; 281(8):526-9. PubMed ID: 2322010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of thymopoietin32-36 and ubiquitin on spontaneous immunopathology of New Zealand mice.
    Gershwin ME; Kruse W; Goldstein G
    J Rheumatol; 1979; 6(6):610-20. PubMed ID: 316825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulation with thymopentin in humans.
    Bolla K; Duchateau J; Delespesse G; Servais G
    Int J Clin Pharmacol Res; 1984; 4(6):431-8. PubMed ID: 6398312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymopentin as adjuvant in non-responders or hyporesponders to hepatitis B vaccination.
    Záruba K; Rastorfer M; Grob PJ; Joller-Jemelka H; Bolla K
    Lancet; 1983 Nov; 2(8361):1245. PubMed ID: 6139582
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunoregulation by thymopoietin.
    Goldstein G; Lau CY
    J Supramol Struct; 1980; 14(3):397-403. PubMed ID: 6971374
    [No Abstract]   [Full Text] [Related]  

  • 18. Thymus-dependent and thymus-independent antibody responses: contrasting patterns of immunosuppression.
    Addison IE; Babbage JW
    Br J Exp Pathol; 1981 Feb; 62(1):74-8. PubMed ID: 6971650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stimulation of immunogenesis by neurotensin, pentagastrin and thymopentin and ways of its realization].
    Belokrylov GA; Molchanova IV; Popova OIa
    Biull Eksp Biol Med; 1989 Nov; 108(11):584-7. PubMed ID: 2699257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of thymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients. -I) In vitro study.
    Auteri A; Laghi Pasini F; Pasqui AL; Bilenchi R; Di Perri T
    Boll Soc Ital Biol Sper; 1980 Feb; 56(4):308-11. PubMed ID: 7018514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.